Summary

The global market for Cardiovascular POCT was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Cardiovascular POCT, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiovascular POCT by region & country, by Type, and by Application.
The Cardiovascular POCT market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular POCT.

Market Segmentation
By Company
Roche
Abbott
BioMerieux
Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Sinocare Inc
Relia Bioengineering Co., Ltd
Beijing Hotgen Biotech Co.,ltd.
Assure Tech (Hangzhou) Co.,Ltd.
Nanjing Vazyme Biotech Co.,Ltd.
Siemens Healthineers
Danaher
Sansure Biotech Inc.
Segment by Type
Based on Immunochromatography
Based on Chemiluminescence Technology
Based on Biosensor
Based on Colloidal Gold
Others
Segment by Application
Hospital
lndependent Testing Organization
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiovascular POCT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cardiovascular POCT in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cardiovascular POCT in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Cardiovascular POCT Product Introduction
1.2 Global Cardiovascular POCT Market Size Forecast
1.2.1 Global Cardiovascular POCT Sales Value (2020-2031)
1.2.2 Global Cardiovascular POCT Sales Volume (2020-2031)
1.2.3 Global Cardiovascular POCT Sales Price (2020-2031)
1.3 Cardiovascular POCT Market Trends & Drivers
1.3.1 Cardiovascular POCT Industry Trends
1.3.2 Cardiovascular POCT Market Drivers & Opportunity
1.3.3 Cardiovascular POCT Market Challenges
1.3.4 Cardiovascular POCT Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiovascular POCT Players Revenue Ranking (2024)
2.2 Global Cardiovascular POCT Revenue by Company (2020-2025)
2.3 Global Cardiovascular POCT Players Sales Volume Ranking (2024)
2.4 Global Cardiovascular POCT Sales Volume by Company Players (2020-2025)
2.5 Global Cardiovascular POCT Average Price by Company (2020-2025)
2.6 Key Manufacturers Cardiovascular POCT Manufacturing Base and Headquarters
2.7 Key Manufacturers Cardiovascular POCT Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cardiovascular POCT
2.9 Cardiovascular POCT Market Competitive Analysis
2.9.1 Cardiovascular POCT Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Cardiovascular POCT Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular POCT as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Based on Immunochromatography
3.1.2 Based on Chemiluminescence Technology
3.1.3 Based on Biosensor
3.1.4 Based on Colloidal Gold
3.1.5 Others
3.2 Global Cardiovascular POCT Sales Value by Type
3.2.1 Global Cardiovascular POCT Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Cardiovascular POCT Sales Value, by Type (2020-2031)
3.2.3 Global Cardiovascular POCT Sales Value, by Type (%) (2020-2031)
3.3 Global Cardiovascular POCT Sales Volume by Type
3.3.1 Global Cardiovascular POCT Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Cardiovascular POCT Sales Volume, by Type (2020-2031)
3.3.3 Global Cardiovascular POCT Sales Volume, by Type (%) (2020-2031)
3.4 Global Cardiovascular POCT Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 lndependent Testing Organization
4.2 Global Cardiovascular POCT Sales Value by Application
4.2.1 Global Cardiovascular POCT Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Cardiovascular POCT Sales Value, by Application (2020-2031)
4.2.3 Global Cardiovascular POCT Sales Value, by Application (%) (2020-2031)
4.3 Global Cardiovascular POCT Sales Volume by Application
4.3.1 Global Cardiovascular POCT Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Cardiovascular POCT Sales Volume, by Application (2020-2031)
4.3.3 Global Cardiovascular POCT Sales Volume, by Application (%) (2020-2031)
4.4 Global Cardiovascular POCT Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Cardiovascular POCT Sales Value by Region
5.1.1 Global Cardiovascular POCT Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Cardiovascular POCT Sales Value by Region (2020-2025)
5.1.3 Global Cardiovascular POCT Sales Value by Region (2026-2031)
5.1.4 Global Cardiovascular POCT Sales Value by Region (%), (2020-2031)
5.2 Global Cardiovascular POCT Sales Volume by Region
5.2.1 Global Cardiovascular POCT Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Cardiovascular POCT Sales Volume by Region (2020-2025)
5.2.3 Global Cardiovascular POCT Sales Volume by Region (2026-2031)
5.2.4 Global Cardiovascular POCT Sales Volume by Region (%), (2020-2031)
5.3 Global Cardiovascular POCT Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Cardiovascular POCT Sales Value, 2020-2031
5.4.2 North America Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Cardiovascular POCT Sales Value, 2020-2031
5.5.2 Europe Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Cardiovascular POCT Sales Value, 2020-2031
5.6.2 Asia Pacific Cardiovascular POCT Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Cardiovascular POCT Sales Value, 2020-2031
5.7.2 South America Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cardiovascular POCT Sales Value, 2020-2031
5.8.2 Middle East & Africa Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiovascular POCT Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Cardiovascular POCT Sales Value
6.2.1 Key Countries/Regions Cardiovascular POCT Sales Value, 2020-2031
6.2.2 Key Countries/Regions Cardiovascular POCT Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Cardiovascular POCT Sales Value, 2020-2031
6.3.2 United States Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Cardiovascular POCT Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Cardiovascular POCT Sales Value, 2020-2031
6.4.2 Europe Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Cardiovascular POCT Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Cardiovascular POCT Sales Value, 2020-2031
6.5.2 China Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
6.5.3 China Cardiovascular POCT Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Cardiovascular POCT Sales Value, 2020-2031
6.6.2 Japan Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Cardiovascular POCT Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Cardiovascular POCT Sales Value, 2020-2031
6.7.2 South Korea Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Cardiovascular POCT Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiovascular POCT Sales Value, 2020-2031
6.8.2 Southeast Asia Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Cardiovascular POCT Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Cardiovascular POCT Sales Value, 2020-2031
6.9.2 India Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
6.9.3 India Cardiovascular POCT Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Roche Cardiovascular POCT Product Offerings
7.1.5 Roche Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Abbott Cardiovascular POCT Product Offerings
7.2.5 Abbott Recent Development
7.3 BioMerieux
7.3.1 BioMerieux Company Information
7.3.2 BioMerieux Introduction and Business Overview
7.3.3 BioMerieux Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 BioMerieux Cardiovascular POCT Product Offerings
7.3.5 BioMerieux Recent Development
7.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
7.4.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
7.4.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Introduction and Business Overview
7.4.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Product Offerings
7.4.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Development
7.5 Guangzhou Wondfo Biotech Co.,Ltd.
7.5.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
7.5.2 Guangzhou Wondfo Biotech Co.,Ltd. Introduction and Business Overview
7.5.3 Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Product Offerings
7.5.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Development
7.6 Getein Biotech, Inc.
7.6.1 Getein Biotech, Inc. Company Information
7.6.2 Getein Biotech, Inc. Introduction and Business Overview
7.6.3 Getein Biotech, Inc. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Getein Biotech, Inc. Cardiovascular POCT Product Offerings
7.6.5 Getein Biotech, Inc. Recent Development
7.7 Sinocare Inc
7.7.1 Sinocare Inc Company Information
7.7.2 Sinocare Inc Introduction and Business Overview
7.7.3 Sinocare Inc Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Sinocare Inc Cardiovascular POCT Product Offerings
7.7.5 Sinocare Inc Recent Development
7.8 Relia Bioengineering Co., Ltd
7.8.1 Relia Bioengineering Co., Ltd Company Information
7.8.2 Relia Bioengineering Co., Ltd Introduction and Business Overview
7.8.3 Relia Bioengineering Co., Ltd Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Relia Bioengineering Co., Ltd Cardiovascular POCT Product Offerings
7.8.5 Relia Bioengineering Co., Ltd Recent Development
7.9 Beijing Hotgen Biotech Co.,ltd.
7.9.1 Beijing Hotgen Biotech Co.,ltd. Company Information
7.9.2 Beijing Hotgen Biotech Co.,ltd. Introduction and Business Overview
7.9.3 Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Product Offerings
7.9.5 Beijing Hotgen Biotech Co.,ltd. Recent Development
7.10 Assure Tech (Hangzhou) Co.,Ltd.
7.10.1 Assure Tech (Hangzhou) Co.,Ltd. Company Information
7.10.2 Assure Tech (Hangzhou) Co.,Ltd. Introduction and Business Overview
7.10.3 Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Product Offerings
7.10.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Development
7.11 Nanjing Vazyme Biotech Co.,Ltd.
7.11.1 Nanjing Vazyme Biotech Co.,Ltd. Company Information
7.11.2 Nanjing Vazyme Biotech Co.,Ltd. Introduction and Business Overview
7.11.3 Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Product Offerings
7.11.5 Nanjing Vazyme Biotech Co.,Ltd. Recent Development
7.12 Siemens Healthineers
7.12.1 Siemens Healthineers Company Information
7.12.2 Siemens Healthineers Introduction and Business Overview
7.12.3 Siemens Healthineers Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Siemens Healthineers Cardiovascular POCT Product Offerings
7.12.5 Siemens Healthineers Recent Development
7.13 Danaher
7.13.1 Danaher Company Information
7.13.2 Danaher Introduction and Business Overview
7.13.3 Danaher Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Danaher Cardiovascular POCT Product Offerings
7.13.5 Danaher Recent Development
7.14 Sansure Biotech Inc.
7.14.1 Sansure Biotech Inc. Company Information
7.14.2 Sansure Biotech Inc. Introduction and Business Overview
7.14.3 Sansure Biotech Inc. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Sansure Biotech Inc. Cardiovascular POCT Product Offerings
7.14.5 Sansure Biotech Inc. Recent Development
8 Industry Chain Analysis
8.1 Cardiovascular POCT Industrial Chain
8.2 Cardiovascular POCT Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiovascular POCT Sales Model
8.5.2 Sales Channel
8.5.3 Cardiovascular POCT Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer